The first exchange-traded fund (ETF) providing direct exposure to XRP prepares to launch this week. Following the considerable attention already garnered by futures-based XRP ETFs, ETF expert Nate Geraci says this debut is a moment that will test the strength of investor interest. Many in the market now wait to see if the new fund […]The first exchange-traded fund (ETF) providing direct exposure to XRP prepares to launch this week. Following the considerable attention already garnered by futures-based XRP ETFs, ETF expert Nate Geraci says this debut is a moment that will test the strength of investor interest. Many in the market now wait to see if the new fund […]

ETF Expert Says Spot XRP ETF Launching This Week Will Test Investors, Here’s How

2025/09/18 05:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The first exchange-traded fund (ETF) providing direct exposure to XRP prepares to launch this week. Following the considerable attention already garnered by futures-based XRP ETFs, ETF expert Nate Geraci says this debut is a moment that will test the strength of investor interest. Many in the market now wait to see if the new fund will draw the same level of attention, or if demand may not be as robust as some hope.

REX-Osprey Uses Regulatory Path To Launch First Spot XRP ETF

According to Nate Geraci, REX-Osprey is launching a new Spot XRP ETF.  He says the company is using the Investment Company Act of 1940 as a creative path, providing a way to move ahead with the launch and bring the fund to market faster without going through the more lengthy and rigorous approval process. The regulatory end-around enables the fund to circumvent the cumbersome process usually associated with the Securities Act of 1933. 

Geraci points out that this means the spot XRP ETF can begin trading now instead of waiting for full regulatory approval, which often takes much longer. For investors, it means they get a chance to test direct XRP exposure sooner than many expected.

Investors Face Key Test Of Demand As Futures ETFs Near $1 Billion

Geraci also explains that this launch will serve as a key test of demand for a proper spot XRP ETF under the ’33 Act framework. He calls it a litmus test, meaning it will show clearly how much appetite investors really have for this type of product. Futures-based XRP ETFs now hold $1 billion in assets, showing investor demand and clear interest in XRP-related products. The debut of the new spot product will make it clear if that same level of enthusiasm extends into direct exposure.

The launch of a spot XRP ETF matters because it extends beyond futures trading. While futures products provide indirect exposure, Geraci explains that this debut will test whether investors, especially institutions, want direct ownership through a spot fund. If the product gains traction, it will demonstrate that demand extends not only to derivatives but also to direct access to XRP itself. 

The question now, according to Geraci, is whether the new spot ETF will experience the same strong flows or if the market is not yet ready to commit to direct exposure fully. If investors invest large amounts, it will demonstrate to regulators and the broader market that demand is high. If flows are weak, interest has limits. 

Geraci says the result of this launch will send a clear signal about how investors see XRP’s role in the ETF market and how ready they are for spot products in the broader crypto industry.

XRP price chart from TradingView.com (XRP ETF)
Market Opportunity
XRP Logo
XRP Price(XRP)
$1.3712
$1.3712$1.3712
-1.53%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11